Expression of a Functional zipFv Antibody Fragment and its Fusions with Alkaline Phosphatase in the Cytoplasm of an Escherichia coli
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Expression of recombinant antibodies and their derivatives fused with other functional molecules such as alkaline phosphatase in Escherichia coli is important in the development of molecular diagnostic reagents for biomedical research. Methods: We investigated the possibility of applying a well-known Fos-Jun zipper to dimerize VH and VL fragments originated from the Fab clone (SP 112) that recognizes pyruvate dehydrogenase complex-E2 (PDC-E2), and demonstrated that the functional zipFv-112 and its alkaline phosphatase fusion molecules (zipFv-AP) can be produced in the cytoplasm of Origami(DE3) trxB gor mutant E. coli strain. Results: The zipFv-AP fusion molecules exhibited higher antigen-binding signals than the zipFv up to a 10-fold under the same experimental conditions. However, conformation of the zipFv-AP seemed to be influenced by the location of an AP domain at the C-terminus of VH or VL domain [zipFv-112(H-AP) or zipFv-112(L-AP)], and inclusion of an AraC DNA binding domain at the C-terminus of VH of the zipFv-112(L-AP), termed zipFv-112(H-AD/L-AP), was also beneficial. Cytoplasmic co-expression of disulfide-binding isomerase C (DsbC) helped proper folding of the zipFv-112(H-AD/L-AP) but not significantly. Conclusion: We believe that our zipFv constructs may serve as an excellent antibody format bi-functional antibody fragments that can be produced stably in the cytoplasm of E. coli.
Abstract
Expression of recombinant antibodies and their derivatives fused with other functional molecules such as alkaline phosphatase in Escherichia coli is important in the development of molecular diagnostic reagents for biomedical research. Methods: We investigated the possibility of applying a well-known Fos-Jun zipper to dimerize VH and VL fragments originated from the Fab clone (SP 112) that recognizes pyruvate dehydrogenase complex-E2 (PDC-E2), and demonstrated that the functional zipFv-112 and its alkaline phosphatase fusion molecules (zipFv-AP) can be produced in the cytoplasm of Origami(DE3) trxB gor mutant E. coli strain. Results: The zipFv-AP fusion molecules exhibited higher antigen-binding signals than the zipFv up to a 10-fold under the same experimental conditions. However, conformation of the zipFv-AP seemed to be influenced by the location of an AP domain at the C-terminus of VH or VL domain [zipFv-112(H-AP) or zipFv-112(L-AP)], and inclusion of an AraC DNA binding domain at the C-terminus of VH of the zipFv-112(L-AP), termed zipFv-112(H-AD/L-AP), was also beneficial. Cytoplasmic co-expression of disulfide-binding isomerase C (DsbC) helped proper folding of the zipFv-112(H-AD/L-AP) but not significantly. Conclusion: We believe that our zipFv constructs may serve as an excellent antibody format bi-functional antibody fragments that can be produced stably in the cytoplasm of E. coli.
참고문헌 (37)
- Morino K, "Antibody fusions with fluorescent proteins: a versatile reagent for profiling protein expression", J Immunol Methods, 257, pp.175~184 (2001)
- Pack P, "Miniantibodies use of amphipathic helices to produce functional, flexibly linked dimeric Fv fragments with high avidity in Escherichia coli", Biochemistry, 31, pp.1579~1584 (1992)
- Horne C, "Noncovalent association of heavy and light chains of human immunoglobulins. III. Specific interactions between VH and VL", J Immunol, 129, pp.660~664 (1982)
- Jäger M, "Domain interactions in antibody Fv and scFv fragments: effects on unfolding kinetics and equilibria", FEBS Lett, 462, pp.307~312 (1999)
- Jäger M, "Folding and assembly of an antibody Fv fragment, a heterodimer stabilized by antigen", J Mol Biol, 285, pp.2005~2019 (1999)
- Huston JS, "Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli", Proc Natl Acad Sci U S A, pp.5879~5883 (1988)
- Bird RE, "Single-chain antigen-binding proteins", Science, 242, pp.423~426 (1988)
- Chaudhary VK, "A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin", Nature, 339, pp.394~397 (1989)
- Glockshuber R, "A comparison of strategies to stabilize immunoglobulin Fv-fragments", Biochemistry, 29, pp.1362~1367 (1990)
- Bird RE, "Single chain antibody variable regions", Trends Biotechnol, 9, pp.132~137 (1991)
- Reiter Y, "Improved binding and antitumor activity of a recombinant anti-erbB2 immunotoxin by disulfide stabilization of the Fv fragment", J Biol Chem, 269, pp.18327~18331 (1994)
- Jung SH, "Design of interchain disulfide bonds in the framework region of the Fv fragment of the monoclonal antibody B3", Protein, 19, pp.35~47 (1994)
- Reiter Y, "Engineering antibody Fv fragments for cancer detection and therapy: disulfide-stabilized Fv fragments", Nat Biotechnol, 14, pp.1239~1245 (1996)
- Reiter Y, "Stabilization of the Fv fragments in recombinant immunotoxins by disulfide bonds engineered into conserved framework regions", Biochemistry, 33, pp.5451~5459 (1994)
- Reiter Y, "Engineering interchain disulfide bonds into conserved framework regions of Fv fragments improved biochemical characteristics of recombinant immunotoxins containing disulfide-stabilized Fv", Protein Eng, 7, pp.697~704 (1994)
- Skerra A, "Assembly of a functional immunoglobulin Fv fragment in Escherichia coli", Science, 240, pp.1038~1041 (1988)
- Krebber A, "Inclusion of an upstream transcriptional terminator in phage display vectors abolishes background expression of toxic fusions with coat protein g3p", Gene, 178, pp.71~74 (1996)
- Clark MA, "Regulation and expression of human Fabs under the control of the Escherichia coli arabinose promoter,PBAD", Immunotechnol, 3, pp.217~226 (1997)
- Knappik A, "Engineered turns of a recombinant antibody improve its in vivo folding", Protein Eng, 8, pp.81~89 (1995)
- Deramn AI, "Mutations that allow disulfide bond formation in the cytoplasm of Escherichia coli", Science, 262, pp.1744~1747 (1993)
- He M, "Functional expression of a single-chain anti-progesterone antibody fragment in the cytoplasm of a mutant Escherichia coli", Nucleic Acids Res, 23, pp.4009~4010 (1995)
- Jurado P, "Production of functional single-chain Fv antibodies in the cytoplasm of Escherichia coli", J Mol Biol, 320, pp.1~10 (2002)
- Levy R, "Production of correctly folded Fab antibody fragment in the cytoplasm of Escherichia coli trxB gor mutants via the coexpression of molecular chaperones", Protein Expr Purif, 23, pp.338~347 (2001)
- Venturi M, "High level production of functional antibody Fab fragments in an oxidizing bacterial cytoplasm", J Mol Biol, 315, pp.1~8 (2002)
- Sambrook J, "Molecular Cloning. 2nd ed." (1989), Cold Spring Harbor Laboratory Press
- Cha S, "Heterogeneity of combinatorial human autoantibodies against PDC-E2 and biliary epithelial cells in patients with primary biliary cirrhosis", Hepatology, 20, pp.574~583 (1994)
- McCafferty J, "Construction and screening of antibody display libraries. In: McCafferty J, Johnson KS, editors. Phage Display of Peptides and Proteins. A Laboratory Manual" (1996), Academic Press Inc.
- Brunelle A, "Determining residue-base interactions between AraC protein and araI DNA", J Mol Biol, 209, pp.607~622 (1989)
- Menon KP, "Activation of ara operons by a truncated AraC protein does not require inducer", Proc Natl Acad Sci U S A, 87, pp.3708~3712 (1990)
- Cha S, "Combinatorial autoantibodies to dihydrolipoamide acetyltransferase, the major autoantigen of primary biliary cirrhosis", Proc Natl Acad Sci U S A, 90, pp.2527~2531 (1993)
- Bustos SA, "Functional domains of the AraC protein", Proc Natl Acad Sci U S A, 90, pp.5638~5642 (1993)
- Röthlisberger D, "Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability", J Mol Biol, 347, pp.773~789 (2005)
- O’shea EK, "ferential heterodimer formation by isolated leucine zipper from fos and jun", Science, 245, pp.646~648 (1989)
- Griep RA, "pSKAP", S: an expression vector for the production of single-chain Fv alkaline phosphatase fusion proteins, 1999, pp.16, 63~69
- Hayhurst A, "Improved expression characteristics of single-chain Fv fragments when fused downstream of the Escherichia coli maltose-binding protein or upstream of a single immunoglobulin-constant domain", Protein Expr Purif, 18, pp.1~10 (2000)
- Strachan G, "Reduced toxicity of expression, in Escherichia coli, of anti pollutant antibody fragments and their use as sensitive diagnostic molecules", J Appl Microbiol, 87, pp.410~417 (1999)
- Bessette PH, "Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm", Proc Natl Acad Sci U S A, 96, pp.13703~13708 (1999)